Abstract. Isolated tuberculosis of the pancreas is rare even in developing countries where abdominal tuberculosis continues to be prevalent. We present a case of pancreatic tuberculosis in an immunocompetent male with confounding imaging findings and non-contributory clinical details.
A 48-year-old male presented with progressive abdominal discomfort and weight loss of 3 months duration. Laboratory investigations revealed total bilirubin of 3.3 mg/dL, aspartate aminotransferase 141 IU, alanine aminotransferase 100 IU, alkaline phosphatase 436 IU, and erythrocyte sedimentation rate of 78 mm the first hour. Computed tomography revealed a well-marginated cystic lesion in the head of the pancreas with upstream biliary dilatation ( Figure 1 ). The remaining abdominal viscera appeared normal with no abdominal lymphadenopathy. The lesion was subjected to endoscopic ultrasound-guided fine needle aspiration; histology revealed epithelioid granulomas. A polymerase chain reaction (PCR)-based assay confirmed presence of Mycobacterium tuberculosis DNA. The patient was initiated on multi-drug anti-tuberculous regimen and remained well 6-months post treatment.
Pancreatic involvement by M. tuberculosis is extremely rare, presumably because of the resistance offered by the pancreatic enzymes 1, 2 ; it is thought to be consequential to bacterial dissemination from regional lymph nodes. Imaging manifestations are variable and can mimic pancreatic malignancy or pancreatitis, frequently presenting as a solid or cystic pancreatic mass with or without regional lymphadenopathy. 1 Findings that suggest a mycobacterial etiology include the presence of centrally necrotic ring-enhancing peripancreatic or mesenteric lymph nodes, presence of ascites, and ileocaecal bowel thickening. Although histopathological illustration of epithelioid cells is highly suggestive, a definitive diagnosis requires demonstration of acid-fast bacilli, isolation of mycobacteria by culture, or molecular detection of mycobacterial DNA in the aspirated material. The majority of the patients respond well to anti-tuberculous therapy.
